These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8384975

  • 1. Immunotoxin therapy of small-cell lung cancer. N901-blocked ricin for relapsed small-cell lung cancer.
    Lynch TJ.
    Chest; 1993 Apr; 103(4 Suppl):436S-439S. PubMed ID: 8384975
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autocrine growth factors and neuroendocrine markers in the development of small-cell lung cancer.
    Johnson BE, Kelley MJ.
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):11-4. PubMed ID: 9516605
    [Abstract] [Full Text] [Related]

  • 6. Anti-tumor activity of a blocked ricin immunotoxin with specificity against the cluster-5A antigen associated with human small-cell lung cancer.
    Zangemeister-Wittke U, Collinson AR, Fisch I, Jones RM, Waibel R, Lehman HP, Stahel RA.
    Int J Cancer; 1993 Jul 30; 54(6):1028-35. PubMed ID: 8392978
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-B4-blocked ricin: a phase I trial of 7-day continuous infusion in patients with B-cell neoplasms.
    Grossbard ML, Lambert JM, Goldmacher VS, Spector NL, Kinsella J, Eliseo L, Coral F, Taylor JA, Blättler WA, Epstein CL.
    J Clin Oncol; 1993 Apr 30; 11(4):726-37. PubMed ID: 7683045
    [Abstract] [Full Text] [Related]

  • 13. Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion.
    Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blättler WA.
    Blood; 1992 Feb 01; 79(3):576-85. PubMed ID: 1370636
    [Abstract] [Full Text] [Related]

  • 14. Potent cytotoxic action of the immunotoxin SWA11-ricin A chain against human small cell lung cancer cell lines.
    Derbyshire EJ, Henry RV, Stahel RA, Wawrzynczak EJ.
    Br J Cancer; 1992 Sep 01; 66(3):444-51. PubMed ID: 1325825
    [Abstract] [Full Text] [Related]

  • 15. Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs.
    Liu C, Lambert JM, Teicher BA, Blättler WA, O'Connor R.
    Blood; 1996 May 01; 87(9):3892-8. PubMed ID: 8611717
    [Abstract] [Full Text] [Related]

  • 16. In vivo studies of whole ricin monoclonal antibody immunoconjugates for the treatment of murine tumours.
    Kanellos J, MacKenzie IF, Pietersz GA.
    Immunol Cell Biol; 1988 May 01; 66 ( Pt 5-6)():403-15. PubMed ID: 3265693
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H, King L, Lasky LC, Vallera DA.
    Cancer Res; 1990 Jun 01; 50(11):3249-56. PubMed ID: 1692258
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL, Duffey PL, Gribben JG, Jaffe ES, Curti BD, Gause BL, Janik JE, Braman VM, Esseltine D, Wilson WH, Kaufman D, Wittes RE, Nadler LM, Urba WJ.
    Cancer J; 2000 Jun 01; 6(3):146-50. PubMed ID: 10882329
    [Abstract] [Full Text] [Related]

  • 19. A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma.
    Grossbard ML, Multani PS, Freedman AS, O'Day S, Gribben JG, Rhuda C, Neuberg D, Nadler LM.
    Clin Cancer Res; 1999 Sep 01; 5(9):2392-8. PubMed ID: 10499609
    [Abstract] [Full Text] [Related]

  • 20. Cytotoxic activity of ricin A chain immunotoxins recognising cluster 1, w4 and 5A antigens associated with human small cell lung cancer.
    Wawrzynczak EJ, Derbyshire EJ, Henry RV, Parnell GD, Smith A, Waibel R, Stahel RA.
    Br J Cancer Suppl; 1991 Jun 01; 14():71-3. PubMed ID: 1645577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.